Peer-reviewedCC BYFrontiers in medicine
Toward precision host-directed immunomodulation in community-acquired pneumonia: a proposed endotype–target–natural-product framework and a roadmap for validation in human lung organoids
- 1Department of Pulmonary Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine , ,
- 2Department of Pulmonary Diseases, Shuguang Hospital, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicine , ,
Related
- Clinical validation of a novel multiplex real-time PCR for diagnosing community-acquired pneumonia in the emergency department: a promising diagnostic tool for Mycoplasma pneumoniae
- Interpretable prediction model for severe community-acquired pneumonia in adults: machine learning development and validation using routine laboratory parameters
- Multi-omics insights into immune dysregulation and candidate biological programs in kawasaki disease: toward precision immunomodulation
- Cell Type- and Phase-Dependent Immune Checkpoint Targeting in Sepsis: TIM-3 as a Model for Precision Immunomodulation.
- Beyond Digoxin Toxicity: A Fatal Case of BRASH Syndrome Triggered by Community-Acquired Pneumonia
BibTeX
@article{shen2026toward,
title = {{Toward precision host-directed immunomodulation in community-acquired pneumonia: a proposed endotype–target–natural-product framework and a roadmap for validation in human lung organoids}},
author = {Qing Shen and Fengjun Zhang and Fan Wu and Yilin Wang and Zijian Su and Guihua Xu and Xing Zhang and Wei Zhang},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655586},
note = {CC BY},
}
RIS
TY - JOUR
TI - Toward precision host-directed immunomodulation in community-acquired pneumonia: a proposed endotype–target–natural-product framework and a roadmap for validation in human lung organoids
AU - Qing Shen
AU - Fengjun Zhang
AU - Fan Wu
AU - Yilin Wang
AU - Zijian Su
AU - Guihua Xu
AU - Xing Zhang
AU - Wei Zhang
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13655586
SN - 2296-858X
ER -